Collaboration on neonatal issues between researchers and the European Medicines Agency

• Date:
  Tuesday, 17 March 2015, All day
• Location:
  European Medicines Agency, Amsterdam, the Netherlands

The aim of the meeting is to develop ways to work together that optimise the design and conduct of neonatal medicines research in Europe. During this meeting we will share perspectives about the current state of neonatal medicines research in Europe, review “hot topics” and prioritise them, and develop an action plan for 2015.Registration by invitation only.

Documents

Agenda - Collaboration on neonatal issues between researchers and the European Medicines Agency

Draft Reference Number: EMA/66870/2015

Presentation - Challenges in newborn drug development: US perspective (Jon Davis)

Presentation - CT for prevention/treatment of BPD (Ninna Gullber)

Presentation - EMA/PDCO approach to neonatology: opportunities (Ralph Bax)

Presentation - Family involvement in research projects: a parental perspective (Silke Mader)

Presentation - Invasive fungal infections (IFI) in neonates: the state of the art (Paolo Manzoni)

Presentation - Neonatal guideline: revision (Siri Wang)

Presentation - Neonatal seizures (Geraldine Boylan, Ronit Pressler)

Presentation - Persistent pulmonary hypertension (PPHN) of the newborn: clinical vs regulatory needs (Marek Migdal)

Presentation - Research plan for the International Neonatal Consortium: specimen topic (Jon Davis)

Presentation - Retinopathy of prematurity (Dina Apele Freimane)

Presentation - Strategies to support neonatal development in Europe (Dirk Mentzer, Ine Skottheim-Rusten)

Presentation - Studies in neonatal fungal infections (Irja Lutsar)